Home > Insider Trading > Filing (0001209191-14-012766)

Filing Details

Accession Number:: 0001209191-14-012766
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-02-20 21:56:09
Reporting Period:: 2014-02-18

Filing Date:: 2014-02-20
Accepted Time:: 2014-02-20 21:56:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
827871	Eagle Pharmaceuticals Inc.	EGRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1225149	Alain Schreiber	C/O Proquest Investments, L.p. 2430 Vanderbilt Beach Road, 108-190 Naples FL 34109		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	Acquisiton	2014-02-18	1,927,986	$0.00	1,966,987	No	4	C	Indirect	By ProQuest Investments IV, L.P.
Common Stock, $0.001 Par Value	Acquisiton	2014-02-18	1,028,613	$0.00	2,995,600	No	4	C	Indirect	By ProQuest Investments IV, L.P.
Common Stock, $0.001 Par Value	Acquisiton	2014-02-18	850,520	$0.00	3,846,120	No	4	C	Indirect	By ProQuest Investments IV, L.P.
Common Stock, $0.001 Par Value	Acquisiton	2014-02-18	569,538	$0.00	4,415,658	No	4	C	Indirect	By ProQuest Investments IV, L.P.
Common Stock, $0.001 Par Value	Acquisiton	2014-02-18	21,837	$0.00	4,437,495	No	4	X	Indirect	By ProQuest Investments IV, L.P.
Common Stock, $0.001 Par Value	Acquisiton	2014-02-18	333,333	$15.00	4,770,828	No	4	P	Indirect	By ProQuest Investments IV, L.P.
Common Stock, $0.001 Par Value	Acquisiton	2014-02-18	62,575	$0.00	62,575	No	4	C	Indirect	By ProQuest Management LLC Plans
Common Stock, $0.001 Par Value	Acquisiton	2014-02-18	9,359	$0.00	71,934	No	4	C	Indirect	By ProQuest Management LLC Plans
Common Stock, $0.001 Par Value	Acquisiton	2014-02-18	357	$0.00	72,291	No	4	X	Indirect	By ProQuest Management LLC Plans

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By ProQuest Investments IV, L.P.
No	4	C	Indirect	By ProQuest Investments IV, L.P.
No	4	C	Indirect	By ProQuest Investments IV, L.P.
No	4	C	Indirect	By ProQuest Investments IV, L.P.
No	4	X	Indirect	By ProQuest Investments IV, L.P.
No	4	P	Indirect	By ProQuest Investments IV, L.P.
No	4	C	Indirect	By ProQuest Management LLC Plans
No	4	C	Indirect	By ProQuest Management LLC Plans
No	4	X	Indirect	By ProQuest Management LLC Plans

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2014-02-18	1,927,986	$0.00	1,927,986	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2014-02-18	1,028,613	$0.00	1,028,613	$0.00
Common Stock	Series B-1 Convertible Preferred Stock	Disposition	2014-02-18	850,520	$0.00	850,520	$0.00
Common Stock	Series C Convertible Preferred Stock	Disposition	2014-02-18	569,538	$0.00	569,538	$0.00
Common Stock	Series C Warrants	Disposition	2014-02-18	98,368	$0.00	98,368	$0.00
Common Stock	Series B-1 Convertible Preferred Stock	Disposition	2014-02-18	62,575	$0.00	62,575	$0.00
Common Stock	Series C Convertible Preferred Stock	Disposition	2014-02-18	9,359	$0.00	9,359	$0.00
Common Stock	Series C Warrants	Disposition	2014-02-18	1,614	$0.00	1,614	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	X	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	X	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	9,360	Indirect	By ProQuest Management LLC

Footnotes

Each share of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series B-1 Convertible Preferred Stock and Series C Convertible Preferred stock automatically converted into one share of the Issuer's Common Stock on a 6.41-for-1 basis immediately prior to the consummation of the Issuer's initial public offering.
The shares are owned by ProQuest Investments IV, L.P. ("Investments IV"), of which ProQuest Associates IV LLC ("Associates IV") is the general partner. Jay Moorin and Alain Schreiber are managing members of Associates IV. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest in such securities.
The shares are held in a ProQuest Management LLC Defined Benefit Pension Plan ("DBPP") FBO Jay Moorin and a ProQuest Management LLC Salary Savings Plan FBO Jay Moorin and for the benefit of certain other individuals. Jay Moorin and Alain Schreiber are trustees of the ProQuest Management LLC DBPP FBO Jay Moorin and the ProQuest Management LLC Salary Savings Plan FB0 Jay Moorin and for the benefit of certain other individuals. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest in such securities.
In accordance with their terms, the Series C Warrants (the "Warrants") were net exercised immediately prior to consummation of the Issuer's initial public offering into shares of Common Stock on a 6.41-for-1 basis.
The shares are owned by ProQuest Management LLC ("ProQuest Management"). The Reporting Person is a managing member of ProQuest Management. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest in such securities
Reflects a 1-for-6.41 reverse stock split, pursuant to which each share of preferred stock became convertible into 1/6.41 of a share of common stock.
The expiration date is not relevant to the conversion of these securities.
In accordance with their terms, the Series C Warrants (the "Warrants") were net exercised at an exercise price of $11.67 immediately prior to closing of the Issuer's initial public offering into shares of common stock.